Corticosteroid Treatment for Community-Acquired Pneumonia - The STEP Trial (STEP)
Corticosteroid Treatment for Community-Acquired Pneumonia A Randomized, Double-blind Study- The STEP Trial
Sponsor: Kantonsspital Aarau
Listed as NCT00973154, this PHASE3 trial focuses on Community-acquired Pneumonia and remains completed. Sponsored by Kantonsspital Aarau, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Dec 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Kantonsspital Aarau
- Kantonsspital Liestal
- University Hospital, Basel, Switzerland
For direct contact, visit the study record on ClinicalTrials.gov .